118 related articles for article (PubMed ID: 38279366)
41. Blue (or purple) toes: chilblains or chilblain lupus-like lesions are a manifestation of Aicardi-Goutières syndrome and familial chilblain lupus.
Prendiville JS; Crow YJ
J Am Acad Dermatol; 2009 Oct; 61(4):727-8. PubMed ID: 19751886
[No Abstract] [Full Text] [Related]
42. [A case of male who was taken systemic lupus erythematosus with chilblain lupus].
Takeda S; Tatara I; Kono K
Ryumachi; 1998 Jun; 38(3):529-33. PubMed ID: 9721562
[TBL] [Abstract][Full Text] [Related]
43. Familial chilblain lupus in a child with heterozygous mutation in SAMHD1 and normal interferon signature.
Linggonegoro DW; Song H; Jones KM; Lee PY; Schmidt B; Vleugels RA; Huang JT
Br J Dermatol; 2021 Sep; 185(3):650-652. PubMed ID: 33887057
[No Abstract] [Full Text] [Related]
44. TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis.
Rego SL; Harvey S; Simpson SR; Hemphill WO; McIver ZA; Grayson JM; Perrino FW
Autoimmunity; 2018 Nov; 51(7):333-344. PubMed ID: 30422000
[TBL] [Abstract][Full Text] [Related]
45. Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutières Syndrome.
Gray EE; Treuting PM; Woodward JJ; Stetson DB
J Immunol; 2015 Sep; 195(5):1939-43. PubMed ID: 26223655
[TBL] [Abstract][Full Text] [Related]
46. Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus.
Lee WF; Fan WL; Tseng MH; Yang HY; Huang JL; Wu CY
Pediatr Rheumatol Online J; 2022 Aug; 20(1):68. PubMed ID: 35964089
[TBL] [Abstract][Full Text] [Related]
47. [Familial chilblain lupus : Type 1 interferonopathy with model character].
Fiehn C
Z Rheumatol; 2017 May; 76(4):322-327. PubMed ID: 28389709
[TBL] [Abstract][Full Text] [Related]
48. Aicardi-Goutières syndrome.
Crow YJ
Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
[TBL] [Abstract][Full Text] [Related]
49. Cutaneous histopathological findings of Aicardi-Goutières syndrome, overlap with chilblain lupus.
Kolivras A; Aeby A; Crow YJ; Rice GI; Sass U; André J
J Cutan Pathol; 2008 Aug; 35(8):774-8. PubMed ID: 18422690
[TBL] [Abstract][Full Text] [Related]
50. Chilblain lupus erythematosus in an adolescent girl.
Bansal S; Goel A
Indian Dermatol Online J; 2014 Nov; 5(Suppl 1):S30-2. PubMed ID: 25506560
[TBL] [Abstract][Full Text] [Related]
51. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus.
Ravenscroft JC; Suri M; Rice GI; Szynkiewicz M; Crow YJ
Am J Med Genet A; 2011 Jan; 155A(1):235-7. PubMed ID: 21204240
[No Abstract] [Full Text] [Related]
52. [Evaluation of the past history of chilblain in cases of systemic lupus erythematosus (SLE) and its similar diseases].
Morioka N; Tsuchida T; Ueda Y; Ishibashi Y
Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):615-22. PubMed ID: 1920892
[TBL] [Abstract][Full Text] [Related]
53. Suppression of
Du H; Xiao N; Zhang S; Zhou X; Zhang Y; Lu Z; Fu Y; Huang M; Xu S; Chen Q
iScience; 2023 Jul; 26(7):107090. PubMed ID: 37416470
[TBL] [Abstract][Full Text] [Related]
54. Typing TREX1 gene in patients with systemic lupus erythematosus.
Fredi M; Bianchi M; Andreoli L; Greco G; Olivieri I; Orcesi S; Fazzi E; Cereda C; Tincani A
Reumatismo; 2015 Jun; 67(1):1-7. PubMed ID: 26150267
[TBL] [Abstract][Full Text] [Related]
55. Phenotypic variability of a TREX1 variant in Aicardi-Goutieres type 1 patients from the Indian subcontinent.
Abraham SSC; Yoganathan S; Koshy B; Oommen SP; Simon A; Mathai S; Korula S; Mathew L; Sathishkumar D; Jasper A; George R; Danda S
Eur J Med Genet; 2021 Sep; 64(9):104291. PubMed ID: 34303877
[TBL] [Abstract][Full Text] [Related]
56. TREX1 mutations are not associated with sporadic inclusion body myositis.
Cox FM; Boon EM; van der Lans CA; Bakker E; Verschuuren JJ; Badrising UA
Eur J Neurol; 2010 Aug; 17(8):1108-9. PubMed ID: 20192983
[TBL] [Abstract][Full Text] [Related]
57. DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.
Sakai T; Miyazaki T; Shin DM; Kim YS; Qi CF; Fariss R; Munasinghe J; Wang H; Kovalchuk AL; Kothari PH; Fermaintt CS; Atkinson JP; Perrino FW; Yan N; Morse HC
J Autoimmun; 2017 Jul; 81():13-23. PubMed ID: 28325644
[TBL] [Abstract][Full Text] [Related]
58. Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients.
Millard LG; Rowell NR
Br J Dermatol; 1978 May; 98(5):497-506. PubMed ID: 656324
[TBL] [Abstract][Full Text] [Related]
59. Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs.
Achleitner M; Kleefisch M; Hennig A; Peschke K; Polikarpova A; Oertel R; Gabriel B; Schulze L; Lindeman D; Gerbaulet A; Fiebig U; Lee-Kirsch MA; Roers A; Behrendt R
J Immunol; 2017 Oct; 199(7):2261-2269. PubMed ID: 28835460
[TBL] [Abstract][Full Text] [Related]
60. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria.
Su WP; Perniciaro C; Rogers RS; White JW
Cutis; 1994 Dec; 54(6):395-9. PubMed ID: 7867381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
